Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.96 USD | +3.10% | +11.19% | +264.18% |
01/05 | Baird Starts Longboard Pharmaceuticals With Outperform Rating, $36 Price Target | MT |
26/03 | Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LONGBOARD PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | +3.10% | +11.19% | +264.18% | +184.46% | - | 854M |
Technical Rankings Surperformance
- Stock Market
- Equities
- LBPH Stock
- Charts Longboard Pharmaceuticals, Inc.
- Comparison Chart